Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. Issue 3 (March 2015)

• Record Type: Journal Article
• Authors: Tully, Claire M; Lambe, Teresa; Gilbert, Sarah C; Hill, Adrian V S
• Is Part Of: Lancet infectious diseases. Volume 15:Issue 3(2015:Mar.)
• Page Start: 356
• Page End: 359
• Publication Date: 2015-03
• Subjects: Communicable diseases -- Periodicals; Infection -- Periodicals; Communicable Diseases -- Periodicals; Infection -- Periodicals; Maladies infectieuses -- Périodiques; Infection -- Périodiques; Communicable diseases; Infection; Periodicals; 616.905
• DOI: 10.1016/S1473-3099(14)71071-0
• Languages: English
• ISSNs: 1473-3099

Abstract

Summary: The epidemic of Ebola virus disease has spread at an alarming rate despite containment efforts. As a result, unprecedented large-scale international response efforts have been made in an attempt to gain control of the outbreak and reduce transmission. Several international consortia have been formed in a remarkable worldwide collaborative effort to expedite trials of two candidate Ebola virus vaccines: cAd3-EBOZ and rVSV-EBOV. In parallel, both vaccines are being manufactured in large amounts to enable future rapid deployment for management of the crisis.